Standards of medical care in diabetes-2006: Response to the American Diabetes Association [12]

Diabetes Care

Volumn 29, Issue 11, 2006, Pages 2563-2564

  Tseng, Kingston H ^a  

^a Pacific Medical Associates   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; HEART INFARCTION; HUMAN; HYPERTENSION; LETTER; MEDICAL CARE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PROTEINURIA; RETINOPATHY;

CHOLESTEROL, HDL; DIABETES MELLITUS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; PRACTICE GUIDELINES;

EID: 33845502776     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0805     Document Type: Letter

References (6)

1. American Diabetes Association: Standards of medical care in diabetes-2006 (Position Statement). Diabetes Care 29 (Suppl. 1):S4 -S42, 2006
2. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, Thom SM: British Hypertension Society Guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 328:634-640, 2004
3. Collins R, Armitage J, Parish S, Sleigh P, Peto R, the Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5,963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005-2016, 2003
4. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH, the CARDS Investigators: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trial. Lancet 364:685-696, 2004
5. Sever PS, Poulter NR, Dahlof B, Wedel H, Collins R, Beevers G, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J: Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA). Diabetes Care 28:1151-1157, 2005
6. Tseng KH: Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA) (Letter). Diabetes Care 28:2595, 2005